Eisai Italy

Eisai Italy is owned by Eisai.

Eisai is one of the...

• Nikkei 225;
• Topix.

Eisai is a company listed under the stock ticker 4523 (JP).

Eisai has a direct presence in 11 countries.

Eisai has 12 subsidiaries including EA Pharma, Eisai Americas and Eisai Australia.

They are in:

• Pharmaceuticals92%
• Biotechnology8%

View the org chart displaying its 2 main executives

Most searched biographies at Eisai Italy

• Massimo Casazza, Learning and Development Manager
• Andrea Pecori, Head Value and Access Department

Create your alert
to follow the executive moves at Eisai Italy.

Eisai has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Eisai Italy

Social media about Eisai Italy

• Eisai Italy on Wikipedia, Google News & Yahoo Finance
• Eisai Italy on LinkedIn, Twitter & YouTube

Contact by email its executives including Andrea Pecori

Call Eisai Italy at +39 ...

View the org chart

Register to receive your alert

Report an error